Literature DB >> 22120376

Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006.

Gabriel Zada1, Aaron E Bond, Ya-Ping Wang, Steven L Giannotta, Dennis Deapen.   

Abstract

BACKGROUND: This study sought to determine incidence trends of the anatomical origin of primary malignant brain tumors.
METHODS: Incidence data for histologically confirmed brain tumors were obtained from the Los Angeles County Cancer Surveillance Program (LAC), the California Cancer Registry (CCR), and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program for 1992 to 2006. Age-adjusted incidence rates (AAIR) and annual percent changes (APC) were calculated by histologic subtypes and anatomic subsites. Statistical analyses were performed using the SEER*Stat analytic software and SAS statistical software.
RESULTS: Increased AAIRs of frontal (APC +2.4% to +3.0%, P ≤ 0.001) and temporal (APC +1.3% to +2.3%, P ≤ 0.027) lobe glioblastoma multiforme (GBM) tumors were observed across all registries, accompanied by decreased AAIRs in overlapping region GBMs (-2.0% to -2.8% APC, P ≤ 0.015). The AAIRs of GBMs in the parietal and occipital lobes remained stable. The AAIR of cerebellar GBMs increased according to CCR (APC +11.9%, P < 0.001). The AAIR of all gliomas, which includes all anatomical subsites, decreased (-0.5% to -0.8% APC, P ≤ 0.034). Low-grade and anaplastic astrocytomas demonstrated decreased AAIRs in the majority of brain regions.
CONCLUSIONS: Data from 3 major cancer registries demonstrate increased incidences of GBMs in the frontal lobe, temporal lobe, and cerebellum, despite decreased incidences in other brain regions. Although this may represent an effect of diagnostic bias, the incidence of both large and small tumors increased in these regions. The cause of these observed trends is unknown.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22120376     DOI: 10.1016/j.wneu.2011.05.051

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  18 in total

1.  Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Authors:  Sheng Han; Xiang Li; Bo Qiu; Tao Jiang; Anhua Wu
Journal:  J Neurooncol       Date:  2015-05-26       Impact factor: 4.130

2.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  L Lloyd Morgan
Journal:  Neuro Oncol       Date:  2015-01-20       Impact factor: 12.300

3.  Tumor cohesion and glioblastoma cell dispersal.

Authors:  Ramsey A Foty
Journal:  Future Oncol       Date:  2013-08       Impact factor: 3.404

4.  Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.

Authors:  Jeffrey S Wefel; Kyle R Noll; Ganesh Rao; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2016-08-30       Impact factor: 12.300

5.  Incidence of glioma in a northwestern region of England, 2006-2010.

Authors:  Emily A J Sehmer; G J Hall; David C Greenberg; Catherine O'Hara; Sarah C Wallingford; Karen A Wright; Adèle C Green
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

6.  Handedness and the risk of glioma.

Authors:  Briana Miller; Noah C Peeri; Louis Burt Nabors; Jordan H Creed; Zachary J Thompson; Carrie M Rozmeski; Renato V LaRocca; Sajeel Chowdhary; Jeffrey J Olson; Reid C Thompson; Kathleen M Egan
Journal:  J Neurooncol       Date:  2018-01-13       Impact factor: 4.130

7.  Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells.

Authors:  Qingdi Quentin Li; Rebecca X Lee; Huasheng Liang; Yuhua Zhong
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480

8.  Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency.

Authors:  Wendy L See; I-Li Tan; Joydeep Mukherjee; Theodore Nicolaides; Russell O Pieper
Journal:  Cancer Res       Date:  2012-05-09       Impact factor: 12.701

Review 9.  Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.

Authors:  Jonathan A Edlow; David E Newman-Toker
Journal:  Neurol Clin       Date:  2015-08       Impact factor: 3.787

10.  A Proposed Paradigm Shift in Initializing Cancer Predictive Models with DCE-MRI Based PK Parameters: A Feasibility Study.

Authors:  Alexandros Roniotis; Mariam-Eleni Oraiopoulou; Eleftheria Tzamali; Eleftherios Kontopodis; Sofie Van Cauter; Vangelis Sakkalis; Kostas Marias
Journal:  Cancer Inform       Date:  2015-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.